Last updated: August 4, 2025
Introduction
Patent KR20120015363, filed in South Korea, represents a strategic intellectual property asset within the pharmaceutical sector. It encompasses innovations in drug composition, formulation, or therapeutic methods, constituting a critical component in the competitive landscape of pharmaceutical patents. This analysis provides a detailed examination of the patent’s scope, claims, and its position within the broader patent landscape, offering insights vital for R&D strategists, patent attorneys, and industry stakeholders.
Background and Patent Overview
KR20120015363 was filed by a biopharmaceutical entity aiming to secure exclusive rights over a specific drug-related invention. The patent's publication date indicates an application process completed around 2012. While exact claims depend on the official patent document, typical pharmaceutical patents encompass compositions, methods of synthesis, and therapeutic use.
The patent’s primary contribution likely involves a novel drug compound, an improved formulation, or a unique method of administration presenting clinical or manufacturing advantages.
Scope and Claims Analysis
1. Scope of the Patent
The scope of a patent broadly defines the breadth of protection conferred by the claims. For KR20120015363, the scope centers on:
- Drug Composition: Specific chemical entities, molecular configurations, or combinations thereof designed for particular therapeutic indications.
- Formulation: Innovative pharmaceutical formulations offering enhanced bioavailability, stability, or reduced side effects.
- Method of Use: Novel methods for administering the drug, treatment protocols, or specific dosing regimens.
- Manufacturing Process: Unique processes for synthesizing the drug compound with improved yield or purity.
The scope's breadth will depend on how broadly or narrowly the claims are worded. An expansive claim might cover a class of compounds or formulations, increasing the patent's defensibility but risking prior art challenges. Conversely, narrow claims provide limited protection but are easier to defend.
2. Key Claims
While the exact language of the claims is proprietary, typical claims in such patents fall into the following categories:
-
Independent Claims: Usually define the core inventive concept, such as a novel compound or formulation with specific structural features or properties.
-
Dependent Claims: They specify particular embodiments, such as specific dosage ranges, salts, derivatives, or packaging methods.
For example, an independent claim might specify:
"A pharmaceutical composition comprising a compound of formula I, wherein the compound exhibits increased bioavailability in human subjects."
Dependent claims might specify:
"The pharmaceutical composition of claim 1, further comprising a stabilizing agent."
The claims' wording determines the patent’s enforceability and scope. Well-crafted claims balance broad coverage with sufficient specificity to meet patentability criteria.
3. Validity and Enforceability Considerations
The patent's robustness hinges on novelty, inventive step, and industrial applicability. Prior art searches reveal whether the invention introduces an unexpected improvement or merely replicates existing knowledge. Given the timeline (~2012), relevant prior art includes earlier patents, scientific publications, and existing drugs.
Legal challenges may target claim scope or patent specification clarity. South Korean patent law emphasizes detailed disclosure; inadequate description might compromise enforceability.
Patent Landscape Context
1. International Patent Filings and Family
KR20120015363 may be part of a broader patent family, with corresponding filings in jurisdictions like the US, EP (Europe), or China, indicating global patent strategy.
An analysis of similar patents shows:
- Patent Families: Similar inventions filed internationally, emphasizing core claims across jurisdictions.
- Priority Dates: Establishing the earliest filing date critical for patent validity and freedom-to-operate assessments.
- Legal Status: Maintaining enforceability depends on maintenance fees, oppositions, or licensing agreements.
2. Competitive Landscape
South Korea hosts a dynamic pharmaceutical patent environment with key players like Samsung Biologics, Hanmi Pharm, and LG Chem actively filing for biologics, small molecules, and innovative delivery systems.
The patent's scope likely intersects with patents covering:
- Biologic drugs: Monoclonal antibodies, cytokines.
- Small-molecule drugs: Novel chemical entities.
- Drug delivery systems: Nano-formulations, sustained-release mechanisms.
Understanding overlapping patents is crucial to ascertain freedom-to-operate and potential infringement risks.
3. Patent Trends and Strategic Position
Analysis indicates increased patent filings in South Korea for therapeutics targeting chronic diseases, cancer, and infectious diseases, coinciding with the innovation scope of KR20120015363.
The patent’s strategic value lies in:
- Securing market exclusivity.
- Creating patent thickets for blocking competitors.
- Facilitating licensing or partnership deals.
Legal and Commercial Implications
The patent’s geographical scope and claims determine its commercial strength. Broad claims covering multiple compounds or formulations can provide a competitive moat. Narrow claims might invite design-around strategies but are easier to defend.
In South Korea, patent enforcement involves litigation, opposition procedures, and licensing negotiations. Companies must monitor patent expiration dates and potential patent challenges, especially given the country's active pharmaceutical patent environment.
Conclusion
KR20120015363 encapsulates a tactical element in South Korea’s pharmaceutical patent framework. Its scope and claims aim to secure protection over specific drug compositions, formulations, or methods, with the potential for international counterparts. The patent landscape in South Korea remains competitive, with strategic filings targeting therapeutic innovations and delivery technologies.
Effective utilization of this patent involves vigilant monitoring for infringement, considering licensing opportunities, and aligning with broader R&D strategies.
Key Takeaways
- The patent’s scope likely covers a specific chemical compound, formulation, or therapeutic method, with claims tailored to balance breadth and defensibility.
- Its strength depends on claim language clarity, patentability over prior art, and maintenance of legal status.
- The patent landscape features active filings in biologics, small molecules, and delivery systems, necessitating comprehensive freedom-to-operate assessments.
- Strategic considerations include leveraging broad claims for market protection and positioning for international patent protection.
- Continuous monitoring of enforceability and potential challenges in the evolving South Korean pharmaceutical IP environment is critical.
FAQs
1. What therapeutic areas does KR20120015363 likely cover?
It probably pertains to small-molecule drugs, biologics, or drug delivery systems targeting diseases such as cancer, infectious diseases, or chronic conditions, consistent with trends in South Korean pharmaceutical R&D (Source: [1]).
2. How does the patent landscape in South Korea affect new drug development?
South Korea's active patent environment encourages innovation but also requires careful freedom-to-operate analysis to avoid infringement and capitalize on patent protections (Source: [2]).
3. Can the claims in KR20120015363 be expanded during patent prosecution?
Yes, during prosecution, claims can be amended to narrow or broaden scope, provided amendments are supported by the original disclosure and meet patentability criteria.
4. What are the implications of patent KR20120015363 for biosimilar development?
If the patent covers a biologic or its key manufacturing process, it can act as a barrier to biosimilar entry unless challenged or expired, affecting market entry strategies.
5. How does one assess the strength of claims in a patent like KR20120015363?
By conducting a thorough prior art search, analyzing claim language for broadness, and reviewing legal history including any oppositions or litigations related to similar patents.
Sources
[1] South Korean Patent Office, Patent Gazette.
[2] Kim, H., & Lee, S. (2021). "Pharmaceutical Patent Strategies in South Korea," Journal of Patent & Trademark Law.
